Analytical Data
-
基因名
ANXA11
- Application
-
别名
ANXA11；ANX11；Annexin A11
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P50995
-
表达区间
1-505aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MSYPGYPPPP GGYPPAAPGG GPWGGAAYPP PPSMPPIGLD NVATYAGQFN QDYLSGMAAN MSGTFGGANM PNLYPGAPGA GYPPVPPGGF GQPPSAQQPV PPYGMYPPPG GNPPSRMPSY PPYPGAPVPG QPMPPPGQQP PGAYPGQPPV TYPGQPPVPL PGQQQPVPSY PGYPGSGTVT PAVPPTQFGS RGTITDAPGF DPLRDAEVLR KAMKGFGTDE QAIIDCLGSR SNKQRQQILL SFKTAYGKDL IKDLKSELSG NFEKTILALM KTPVLFDIYE IKEAIKGVGT DEACLIEILA SRSNEHIREL NRAYKAEFKK TLEEAIRSDT SGHFQRLLIS LSQGNRDEST NVDMSLAQRD AQELYAAGEN RLGTDESKFN AVLCSRSRAH LVAVFNEYQR MTGRDIEKSI CREMSGDLEE GMLAVVKCLK NTPAFFAERL NKAMRGAGTK DRTLIRIMVS RSETDLLDIR SEYKRMYGKS LYHDISGDTS GDYRKILLKI CGGND
-
分子量
57 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANXA11, or Annexin A11, is a member of the annexin family of proteins that play crucial roles in various cellular processes, including membrane trafficking, signaling, and apoptosis. Research has shown that ANXA11 is involved in critical physiological processes, such as exocytosis and calcium signaling, and has been implicated in several pathological conditions, including neurodegenerative diseases and cancer. The overexpression or mutation of ANXA11 is associated with developmental disorders and contributes to tumor progression in various cancers, making it a protein of significant interest for both basic and translational research. The recombinant production of ANXA11 enables scientists to study its structural and functional properties in detail, providing insight into its biological roles. Additionally, understanding the interactions of ANXA11 with other cellular proteins can help elucidate its mechanisms of action and potential implications in disease. By developing ANXA11 as a recombinant protein, researchers aim to explore its therapeutic potential and role as a biomarker, paving the way for novel strategies in disease diagnosis and treatment. Overall, the investigation of ANXA11 and its recombinant forms represents a promising avenue of research that may lead to advancements in our understanding of its functions and applications in medicine.
